BACKGROUND Post-tonsillectomy hemorrhage (PTH) has been reported in the literature as a serious complication after tonsillectomy that has high morbidity and can be life threatening. In cases of recurrent secondary PTH, one should consider coagulopathies as the hidden pathology. Factor XIII deficiency is very rare, suggested to be present 1 in 2 million people. Patients with undiagnosed factor X...

assay–typebinding assay, the equilibriumdissociation constant (Kd) for the interactionwas established in the range of 10 M. Based on the measured Kd, it was calculated that in plasma approximately 1% of FXIII-A2 should be in free form. This value was confirmed experimentally by measuring FXIII-A2 in plasma samples immunodepleted of FXIII-A2B2. Free plasma FXIII-A2 is functionally active, and wh...

http://bloodjournal.hematologylibrary.org/content/93/3/897.full.html Updated information and services can be found at: (2497 articles) Hemostasis, Thrombosis, and Vascular Biology • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in i...

The first step of coagulation factor XIII (FXIII) activation involves cleavage of the FXIII activation peptide (FXIII-AP) by thrombin. However, it is not known whether the FXIII-AP is released into plasma upon cleavage or remains attached to activated FXIII. The aim of the present work was to study the structure of free FXIII-AP, develop an assay for FXIII-AP determination in human plasma, and ...

A congenital deficiency of the coagulation Factor XIII A subunit (F XIII A) is a rare autosomal recessive disorder that is characterized by a life-long bleeding tendency complicated by a difficulty in healing. Thus far, no molecular genetic analysis of this disorder has been reported. In this study, we demonstrate the molecular abnormalities in a family with this disorder. We performed Northern...

My good fortune brought me in contact with Albert Szent-Györgyi at the beginning of 1932 and my life became closely associated with his laboratory for fifteen years. The list of succesful scientists who spent a number of years there at time, who became well-known biochemists on their own is very impressive. Some are already lost, like Kalman Laki, Mihaly Gerendas, Jeno Ernst, Bela Gozsy, Laszlo...

We show both theoretically and experimentally that frequency-shifted feedback (FSF) lasers seeded with a single frequency laser can generate Fourier transform-limited pulses with a repetition rate tunable and limited by the spectral bandwidth of the laser. We demonstrate experimentally in a FSF laser with a 150 GHz spectral bandwidth, the generation of 6 ps-duration pulses at repetition rates t...

PURPOSE OF REVIEW Here we review recent developments concerning the diagnosis, classification and treatment of factor XIII (FXIII) deficiency and new findings related to the pathogenesis of the disease. RECENT FINDINGS Most recently, the International Society on Thrombosis and Haemostasis, Scientific and Standardization Committee published a guideline for the diagnosis and classification of F...

Factor XIII (plasma transglutaminase, fibrin stabilizing factor) is a glycoprotein that circulates in blood as a tetramer (a2b2) consisting of two a and two b subunits. The primary structures of the a and b subunits of human factor XIII have been reported by a combination of cDNA cloning and amino acid sequence analysis. To establish the gene structure of the a subunit for factor XIII, several ...